About Biofourmis
Biofourmis is a company based in Boston (United States) founded in 2015 by Maulik Majmudar and Kuldeep Singh Rajput.. Biofourmis has raised $461 million across 6 funding rounds from investors including Aviva, CVS Health and Fangzhou Jianke. Biofourmis has completed 2 acquisitions, including Biovotion and Gaido Health. Biofourmis offers products and services including Biofourmis Platform, Hospital at Home, and Drug Development Tools. Biofourmis operates in a competitive market with competitors including Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health, among others.
- Headquarter Boston, United States
- Founders Maulik Majmudar, Kuldeep Singh Rajput
- Stage Unicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofourmis India Private Limited
- Date of Incorporation 08 Nov, 2017
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$11.54 M (USD)111.44as on Mar 31, 2023
-
Net Profit
$1.18 M (USD)113.75as on Mar 31, 2023
-
EBITDA
$1.97 M (USD)92.93as on Mar 31, 2023
-
Total Equity Funding
$461 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series D
Jul 27, 2022
-
Investors
Aviva
& 13 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Biovotion
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biofourmis
Biofourmis offers a comprehensive portfolio of products and services, including Biofourmis Platform, Hospital at Home, and Drug Development Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for remote monitoring and care delivery services.
Solution enabling home-based hospital services and patient management.
Tools for managing drug life cycles and clinical trials.
Unlock access to complete
Software Development Team
28 people
Leadership Team
13 people
Finance and Accounting
7 people
Product Management Team
4 people
Human Resources and Administration
3 people
Legal and Compliance
3 people
Customer Team
2 people
Senior Team
2 people
Unlock access to complete
Funding Insights of Biofourmis
Biofourmis has successfully raised a total of $461M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $20.0M
-
First Round
First Round
(11 Aug 2017)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series D - Biofourmis | Valuation | Intel Capital |
|
| Apr, 2022 | Amount | Series D - Biofourmis | Valuation | General Atlantic | |
| Sep, 2020 | Amount | Series C - Biofourmis | Valuation | SoftBank Vision Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofourmis
Biofourmis has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Aviva, CVS Health and Fangzhou Jianke. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in technology startups focusing on compute, AI, and related innovations.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location | |
|
Early-stage technology startups are invested in by Openspace Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofourmis
Biofourmis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Biovotion and Gaido Health. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-enabled early detection services for healthcare are provided.
|
2018 | ||||
|
Patient health vitals are monitored remotely via Biovotion's wearable devices.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biofourmis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofourmis Comparisons
Competitors of Biofourmis
Biofourmis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based data analytics are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Provider of AI solutions for clinical, operational, and business outcomes
|
|
| domain | founded_year | HQ Location |
EHR Platform with integrated Telehealth, Mobile health and RCM solutions for healthcare providers
|
|
| domain | founded_year | HQ Location |
Suite of practice management, reimbursement, laboratory and analytics solutions to healthcare providers
|
|
| domain | founded_year | HQ Location |
Provider of healthcare technology and services for revenue cycle management and clinical support
|
|
| domain | founded_year | HQ Location |
E-prescription and secure messaging solutions are offered to healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofourmis
Frequently Asked Questions about Biofourmis
When was Biofourmis founded?
Biofourmis was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Biofourmis located?
Biofourmis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Biofourmis?
Kuldeep Singh Rajput is the current CEO of Biofourmis. They have also founded this company.
Is Biofourmis a funded company?
Biofourmis is a funded company, having raised a total of $461M across 6 funding rounds to date. The company's 1st funding round was a Series C of $100M, raised on Aug 11, 2017.
What is the annual revenue of Biofourmis?
Annual revenue of Biofourmis is $11.54M as on Mar 31, 2023.
What does Biofourmis do?
Biofourmis was founded in 2015 in Boston, United States, within the healthcare sector. Cloud-based suite solutions are provided for virtual care and patient monitoring. The Biovitals product is utilized for tracking patient engagement, communication, and vital signs. Clinical workflows and electronic health records are integrated to support care coordination across organizations. Operations focus on remote monitoring and data-driven healthcare delivery.
Who are the top competitors of Biofourmis?
Biofourmis's top competitors include IKS Health, Innovaccer and CompuGroup Medical.
What products or services does Biofourmis offer?
Biofourmis offers Biofourmis Platform, Hospital at Home, and Drug Development Tools.
How many acquisitions has Biofourmis made?
Biofourmis has made 2 acquisitions, including Biovotion, and Gaido Health.
Who are Biofourmis's investors?
Biofourmis has 14 investors. Key investors include Aviva, CVS Health, Fangzhou Jianke, General Atlantic, and Peak XV Partners.
What is Biofourmis's valuation?
The valuation of Biofourmis is $1.3B as of Apr 2022.